Pages that link to "Q28258994"
Jump to navigation
Jump to search
The following pages link to Causes and consequences of microRNA dysregulation in cancer (Q28258994):
Displaying 50 items.
- Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection (Q21134914) (← links)
- MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells (Q21134916) (← links)
- miRNA expression in colon polyps provides evidence for a multihit model of colon cancer (Q21135357) (← links)
- miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization (Q21135455) (← links)
- Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line (Q21136096) (← links)
- MicroRNAs and their target gene networks in breast cancer (Q21195211) (← links)
- Computational prediction of MicroRNAs targeting GABA receptors and experimental verification of miR-181, miR-216 and miR-203 targets in GABA-A receptor (Q21199582) (← links)
- Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits (Q21245759) (← links)
- miR-449 inhibits cell proliferation and is down-regulated in gastric cancer (Q21245766) (← links)
- MiR-200c and HuR in ovarian cancer (Q21261258) (← links)
- Research recommendations for selected IARC-classified agents (Q23912511) (← links)
- Processing of microRNA primary transcripts requires heme in mammalian cells (Q24322527) (← links)
- Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs (Q24338738) (← links)
- Functional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infection (Q24490032) (← links)
- Cancer microRNAs: from subtype profiling to predictors of response to therapy (Q24863739) (← links)
- NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes (Q24596715) (← links)
- The dicey role of Dicer: implications for RNAi therapy (Q24597854) (← links)
- Inhibition and role of let-7d in idiopathic pulmonary fibrosis (Q24599153) (← links)
- Secretory mechanisms and intercellular transfer of microRNAs in living cells (Q24603413) (← links)
- Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway (Q24607221) (← links)
- A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation (Q24608565) (← links)
- The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases (Q24608620) (← links)
- Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy (Q24609974) (← links)
- The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence (Q24617045) (← links)
- MicroRNAs in mouse models of lymphoid malignancies (Q24618980) (← links)
- Network of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genes (Q24619351) (← links)
- MicroRNA-124a and microRNA-34b/c are frequently methylated in all histological types of colorectal cancer and polyps, and in the adjacent normal mucosa (Q24623009) (← links)
- Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation (Q24624985) (← links)
- MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) (Q24630209) (← links)
- Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis (Q24630773) (← links)
- MicroRNAs and Metastasis: Little RNAs Go a Long Way (Q24631373) (← links)
- Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis (Q24631440) (← links)
- Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia (Q24633394) (← links)
- Tumorigenicity of the miR-17-92 cluster distilled (Q24650776) (← links)
- miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma (Q24658453) (← links)
- Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic Acids (Q26744516) (← links)
- The Quest for Targets Executing MYC-Dependent Cell Transformation (Q26744579) (← links)
- MicroRNA Target Recognition: Insights from Transcriptome-Wide Non-Canonical Interactions (Q26749540) (← links)
- Small Non-coding RNAs Associated with Viral Infectious Diseases of Veterinary Importance: Potential Clinical Applications (Q26752417) (← links)
- Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity (Q26766173) (← links)
- Role of microRNA-7 in digestive system malignancy (Q26769922) (← links)
- MicroRNA and Pathogenesis of Enterovirus Infection (Q26769980) (← links)
- Studies of Tumor Suppressor Genes via Chromosome Engineering (Q26771240) (← links)
- Micro-Ribonucleic Acid and Carcinogenesis: Breast Cancer as an Example (Q26771418) (← links)
- Cancer stem cells: a metastasizing menace! (Q26771651) (← links)
- Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis (Q26777068) (← links)
- Translating cancer genomes and transcriptomes for precision oncology (Q26777081) (← links)
- Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays (Q26777992) (← links)
- MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis (Q26785371) (← links)
- Diagnostic Value of MicroRNAs for Urologic Cancers: A Systematic Review and Meta-Analysis (Q26786185) (← links)